A Real‐World Study on the Characteristics, Treatment Patterns, and Healthcare Resource Utilization in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Systemic Treatment in China

Documenti analoghi

• Real‐World Experience of Secukinumab Treatment in Patients with Moderate‐to‐Severe Plaque Psoriasis in Greece: 3‐Year Interim Results of the SERENA Study
  di: Dimitrios Ioannides, et al.
  Pubblicazione: (2024)
• The Impact of Obesity on Response to Secukinumab in Pediatric Plaque Psoriasis: A Real‐World Study
  di: Zhaoyang Wang, et al.
  Pubblicazione: (2025)
• Real‐World Effectiveness and Safety of Biologic Switches in Chinese Patients With Plaque Psoriasis: A Single‐Center Retrospective Study
  di: Yu-Ting Gan, et al.
  Pubblicazione: (2025)
• Hepatitis B Reactivation in Biologic‐Treated Moderate‐to‐Severe Psoriasis: A Real‐World Cohort Study With 534 Patient‐Years of Follow‐Up
  di: Neslihan Demirel Öğüt, et al.
  Pubblicazione: (2026)
• Real‐World Impact of Calcipotriol/Betamethasone Dipropionate Aerosol Foam on Quality of Life in Patients With Plaque Psoriasis: A Prospective Observational Study
  di: Tiago Torres, et al.
  Pubblicazione: (2025)